Portfolio comparison
Penn State Research Foundation vs Nektar Therapeutics
Side-by-side portfolio analysis — patents indexed, year ranges, and activity timeline.
Company A
Penn State Research Foundation
Patents indexed
1
Year range
2017
Most recent
2017
biotechpharmaceutical
Top Patents1 enriched
US RE46290· 2017
Using the Drug TIC10 to Treat Brain Cancer
Activity by Decade
2010s1
Company B
Nektar Therapeutics
Patents indexed
1
Year range
2007
Most recent
2007
biotechpharmaceuticalmaterials
Top Patents1 enriched
US RE39497· 2007
How to Store Fragile Biological Materials Without Refrigeration
Activity by Decade
2000s1
How to use
Bookmark a comparison URL to save it. Format: /compare/companies?a=[slug]&b=[slug]. Also see patent-level comparison.